What is Alnylam Pharmaceuticals's total revenue?

Alnylam Pharmaceuticals (ALNY) reported total revenue of $1.17B in Q1 2026.

How has Alnylam Pharmaceuticals's total revenue changed year-over-year?

Alnylam Pharmaceuticals's total revenue increased by 96.4% year-over-year, from $594.19M to $1.17B.

What is the long-term trend for Alnylam Pharmaceuticals's total revenue?

Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's total revenue has grown at a 44.8% compound annual growth rate (CAGR), from $844.29M to $3.71B.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Alnylam Pharmaceuticals ALNY Total Revenue

Total Revenue at other companies

Ionis PharmaceuticalsIONS

$246.09M+87.0%

Arrowhead ResearchARWR

$73.74M-86.4%

PTC TherapeuticsPTCT

$272.55M-76.8%

Assembly BiosciencesASMB

$8.21M-12.8%

Arbutus Biopharma CorporationABUS

$179.13M+10,055%

Wave Life SciencesWVE

$38.25M+317%

Segments

By product

See full

AMVUTTRA$685.3M—

GIVLAARI$73.87M—

OXLUMO$52.83M—

ONPATTRO$39.08M—

Other financials

Income statement

See full

Gross profit$959.7M+83.1%

Operating income$268.6M+1,386%

Net income$206.0M+1,229%

EPS (diluted)$1.51+1,179%

Balance sheet

See full

Cash & equivalents$1.7B+67.5%

Total debt$263.7M-4.5%

Total equity$1.1B+152%

Total assets$5.1B+21.7%

Cash flow

See full

Operating cash flow$70.5M+159%

CapEx$21.8M+143%

Free cash flow$48.7M+138%

Valuation

See full

Market cap$38.9B-8.2%

Enterprise value$37.45B-9.8%

P/E77.4×—

P/S9.1×-8.1×

Profitability

See full

Gross margin81%-5.3pp

Operating margin17.5%+14.4pp

Net margin11.7%+8.0pp

FCF margin15%+12.7pp

Returns & leverage

See full

Return on equity66.9%—

Debt / equity0.2×-0.4×

Current ratio3.1×+0.1×

Where this comes from

Reported directly by Alnylam Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Alnylam Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alnylam Pharmaceuticals's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alnylam Pharmaceuticals's total revenue?: Alnylam Pharmaceuticals (ALNY) reported total revenue of $1.17B in Q1 2026.
How has Alnylam Pharmaceuticals's total revenue changed year-over-year?: Alnylam Pharmaceuticals's total revenue increased by 96.4% year-over-year, from $594.19M to $1.17B.
What is the long-term trend for Alnylam Pharmaceuticals's total revenue?: Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's total revenue has grown at a 44.8% compound annual growth rate (CAGR), from $844.29M to $3.71B.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.